Results 41 to 50 of about 17,377 (218)
Hypertrophic cardiomyopathy is the most common inherited cardiomyopathy, with a prevalence of 1:200 to 1:500. Cardiac amyloidosis, another cardiomyopathy caused by myocardial deposition of abnormally folded TTR protein, can be acquired or hereditary. The presence of pathogenic TTR gene variants in patients with phenotypic HCM is an underrecognized and ...
Kanelidis, Anthony J. +6 more
openaire +4 more sources
Baseline characteristics of patients with ATTR cardiac amyloidosis.
Data are presented as percentages, as appropriate. Abbreviations: ATTR, transthyretin amyloidosis. (DOCX)
Zaza Iakobishvili (505022) +6 more
core +1 more source
Cryo-EM structure of an ATTRwt amyloid fibril from systemic non-hereditary transthyretin amyloidosis
This manuscript reports the structure of a pathologically relevant wild type ATTR amyloid fibril from systemic non-hereditary transthyretin amyloidosis.
Maximilian Steinebrei +6 more
doaj +1 more source
Structural basis for transthyretin amyloid formation in vitreous body of the eye
Systemic ATTR amyloidosis causes the abnormal accumulation of ATTR fibrils formed from the human plasma protein transthyretin (TTR) in multiple organs including the eye.
Irina Iakovleva +5 more
doaj +1 more source
Abstract Aims This study aimed to evaluate the change of the main electrocardiographic (ECG) characteristics and their prognostic role across the main subtypes of cardiac amyloidosis [light‐chain amyloidosis (AL) and hereditary (ATTRv) and wild‐type transthyretin amyloidosis (ATTRwt)].
Alessia Argirò +20 more
wiley +1 more source
Val122Ile mt-ATTR Has a Worse Survival Than wt-ATTR Cardiac Amyloidosis
Maurer et al. [(1)][1] reported results from the THAOS (Transthyretin Amyloid Outcome Survey) registry of transthyretin cardiac amyloid (ATTR) amyloidosis, in which they compared differences between patients carrying wild-type ATTR (wt-ATTR) cardiac amyloidosis and those carrying the mutant ...
Avinainder, Singh +2 more
openaire +2 more sources
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya +9 more
wiley +1 more source
ATTR Variant Amyloidosis in Patients with Dysphagia
Amyloidosis is a rare disease characterized by the accumulation of misfolded extracellular proteins in various organs. Over 30 precursor proteins have been identified that can form amyloid deposits in different parts of the body.
Christina Hui Lee Ng +2 more
core +1 more source
Abstract Aims Transthyretin amyloid cardiomyopathy (ATTR‐CM) is an increasinglyrecognized cause of heart failure with preserved ejection fraction (HFpEF), which may be diagnosed non‐invasively using 99mTc 3,3‐diphosphono‐1,2‐propanodicarboxylic acid (DPD) scintigraphy‐based diagnostic criteria.
L. Healy +15 more
wiley +1 more source
Background Transthyretin amyloidosis cardiomyopathy (ATTR-CM) patients are often older and may be at risk for obstructive epicardial coronary artery disease (oeCAD).
Rana Hassan +4 more
doaj +1 more source

